Will Insiders Be Tempted To Buy More RGLS At The New 52-Week Low?

In trading on Thursday, shares of Regulus Therapeutics Inc (RGLS) touched a new 52-week low of $5.80/share. That's a $15.42 share price drop, or -72.67% decline from the 52-week high of $21.22 set back on 03/05/2015..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.